Allergy

Evidence-based management of anaphylaxis
pp. 827-829(3)
Authors: Simons, F. E. R.; Sheikh, A.

H₁-antihistamines for the treatment of anaphylaxis: Cochrane systematic review
pp. 830-837(8)
Authors: Sheikh, A.; ten Broek, V.; Brown, S. G. A.; Simons, F. E. R.

Comparison of international guidelines for the emergency medical management of anaphylaxis
pp. 838-841(4)
Authors: Alrasbi, M.; Sheikh, A.

Nonallergic angioedema: role of bradykinin
pp. 842-856(15)
Authors: Bas, M.; Adams, V.; Suvorava, T.; Niehues, T.; Hoffmann, T. K.; Kojda, G.

The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology
pp. 857-871(15)
Authors: Muraro, A.; Roberts, G.; Clark, A.; Eigenmann, P. A.; Halken, S.; Lack, G.; Moneret-Vautrin, A.; Niggemann, B.; Rancé, F.

Clinical presentation and time course in hypersensitivity reactions to β-lactams
pp. 872-876(5)
Authors: Bousquet, P. J.; Kvedariene, V.; Co-Minh, H.-B.; Martins, P.; Rongier, M.; Arnoux, B.; Demoly, P.

Anaphylaxis and toxic epidermal necrolysis or Stevens-Johnson syndrome after nonmucosal topical drug application: fact or fiction?
pp. 877-883(7)
Authors: Sachs, B.; Fischer-Barth, W.; Erdmann, S.; Merk, H. F.; Seebeck, J.

Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy
pp. 884-889(6)
Authors: Sturm, G. J.; Heinemann, A.; Schuster, C.; Wiednig, M.; Groselj-Strele, A.; Sturm, E. M.; Aberer, W.

Genetic differences in omega-gliadins involved in two different immediate food hypersensitivities to wheat
pp. 890-896(7)
Authors: Laurière, M.; Pecquet, C.; Boulenc, É.; Bouchez-Mahiout, I.; Snégaroff, J.; Choudat, D.; Raison-Peyron, N.; Vigan, M.; Branlard, G.

Enhancement of hazelnut extract for IgE testing by recombinant allergen spiking
pp. 897-904(8)
Authors: Andersson, K.; Ballmer-Weber, B. K.; Cistero-Bahima, A.; Östling, J.; Lauer, I.; Vieths, S.; Lidholm, J.

Placebo reactions in double-blind, placebo-controlled food challenges in children
pp. 905-912(8)
Authors: Vlieg-Boerstra, B. J.; van der Heide, S.; Bijleveld, C. M. A.; Kukler, J.; Duiverman, E. J.; Dubois, A. E. J.

Cashew nut causes more severe reactions than peanut: case-matched comparison in 141 children
pp. 913-916(4)
Authors: Clark, A. T.; Anagnostou, K.; Ewan, P. W.

The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis
pp. 917-925(9)
Authors: Hu, Y.; Matsumoto, Y.; Dogru, M.; Okada, N.; Igarashi, A.; Fukagawa, K.; Tsubota, K.; Fujishima, H.

PPARγ expression profile and its cytokine driven regulation in atopic dermatitis
pp. 926-933(8)
Authors: Dahten, A.; Mergemeier, S.; Worm, M.

IL-5 and IL-5 receptor alpha polymorphisms are associated with atopic dermatitis in Koreans
pp. 934-942(9)
Authors: Namkung, J.-H.; Lee, J.-E.; Kim, E.; Cho, H.-J.; Kim, S.; Shin, E.-S.; Cho, E.-Y.; Yang, J.-M.

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study
pp. 943-948(6)
Authors: Jacobsen, L.; Niggemann, B.; Dreborg, S.; Ferdousi, H. A.; Halken, S.; Høst, A.; Koivikko, A.; Norberg, L. A.; Valovirta, E.; Wahn, U.; Möller, C.

Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy
pp. 949-953(5)
Authors: Savolainen, J.; Nieminen, K.; Laaksonen, K.; Laiho, T.; Jacobsen, L.; Lahesmaa, R.; Terho, E. O.; Valovirta, E.

Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage
pp. 954-957(4)
Authors: Durham, S. R.; Riis, B.

Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy
pp. 958-961(4)
Authors: Calderon, M. A.; Birk, A. O.; Andersen, J. S.; Durham, S. R.

Anaphylaxis following the first ingestion of lychee fruit: clinical features and immunological cross-reactivity implications
pp. 962-963(2)
Authors: Garrido, S.; García, B. E.; Echechipía, S.; Sanz, M. L.; Ariz, S.; Tabar, A. I.

Beekeepers anaphylaxis: successful immunotherapy covered by omalizumab
pp. 963-964(2)
Authors: Schulze, J.; Rose, M.; Zielen, S.

Anaphylaxis to piperacillin-tazobactam despite a negative penicillin skin test
pp. 964-965(2)
Authors: Rank, M. A.; Park, M. A.

Death due to anaphylactic shock after ingestion of Imodium instants (Loperamide)
pp. 965-966(2)
Authors: Srinivasa, M. R.; Phelan, C.

Treatment with American Polistes venom was ineffective in an Italian patient allergic to European Polistes
pp. 966-967(2)
Authors: Bonadonna, P.; Caruso, B.; Labardi, D.; Dama, A.; Senna, G.; Passalacqua, G.

Corrigenda
pp. 968-968(1)

Corrigenda
pp. 968-968(1)